These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6465702)

  • 61. Determination of serum oxalate using peroxyoxalate chemiluminescence of free oxalic acid.
    Albrecht S; Hornak H; Freidt T; Böhm WD; Weis K; Reinschke A
    J Biolumin Chemilumin; 1993; 8(1):21-4. PubMed ID: 8475780
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ascorbic acid as suspected cause of oxalate nephrotoxicosis in a goat.
    Adair HS; Adams WH
    J Am Vet Med Assoc; 1990 Dec; 197(12):1626-8. PubMed ID: 2276961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Levels of serum ascorbate and its metabolites in hemodialysis patients].
    Hirano H; Tone Y; Otani H; Oya M; Kimura K; Saika Y; Fujii R; Mune M; Ichinose M; Yukawa S
    Nihon Jinzo Gakkai Shi; 2004 Jul; 46(5):426-33. PubMed ID: 15446598
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Oxalic acid--important uremic toxin].
    Mydlík M; Derzsiová K
    Vnitr Lek; 2010 Jul; 56(7):695-701. PubMed ID: 20842915
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ascorbic acid depletion in chronic hemodialysis patients.
    Burge J; Park HS
    Mich Med; 1973 Aug; 72(24):533-4. PubMed ID: 4726738
    [No Abstract]   [Full Text] [Related]  

  • 66. Erythropoietin and iron: the role of ascorbic acid.
    Tarng DC; Huang TP; Wei YH
    Nephrol Dial Transplant; 2001; 16 Suppl 5():35-9. PubMed ID: 11509682
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is vitamin C intake too low in dialysis patients?
    Raimann JG; Levin NW; Craig RG; Sirover W; Kotanko P; Handelman G
    Semin Dial; 2013; 26(1):1-5. PubMed ID: 23106569
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Personal experiences in the long-term treatment of cystine lithiasis with high-dose ascorbic acid].
    Brundig P; Börner R; Berg W
    Z Urol Nephrol; 1982 Nov; 75(11):759-70. PubMed ID: 7164603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients.
    Chan D; Irish A; Croft KD; Dogra G
    Nephrol Dial Transplant; 2006 Jan; 21(1):234-5. PubMed ID: 16204285
    [No Abstract]   [Full Text] [Related]  

  • 70. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study.
    Sirover WD; Siddiqui AA; Benz RL
    Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementation.
    Liu Y; Weisberg LS; Langman CB; Logan A; Hunter K; Prasad D; Avila J; Venkatchalam T; Berns JS; Handelman GJ; Sirover WD
    Clin Biochem; 2016 Oct; 49(15):1133-1139. PubMed ID: 27265723
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum oxalic acid in uremia: effect of a low-protein diet supplemented with essential amino acids and ketoanalogues.
    Barsotti G; Cristofano C; Morelli E; Meola M; Lupetti S; Giovannetti S
    Nephron; 1984; 38(1):54-6. PubMed ID: 6472531
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary oxalosis mimicking hyperparathyroidism diagnosed after long-term hemodialysis.
    Canavese C; Salomone M; Massara C; Portigliatti Barbos M; Cadario A; Pavan I; Marangella M; Petrarulo M; Rotolo U
    Am J Nephrol; 1990; 10(4):344-9. PubMed ID: 2240064
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oxalate removal by differing dialysis techniques.
    Dell'Aquila R; Feriani M; Mascalzoni E; Bragantini L; Ronco C; La Greca G
    ASAIO J; 1992; 38(4):797-800. PubMed ID: 1450473
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Corneal opacity in a contact lens wearer on hemodialysis for renal failure].
    Peter S; Mestel S; Thaler M; Reichart E; Mennel S
    Ophthalmologe; 2012 Jan; 109(1):68-70. PubMed ID: 21956749
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum ascorbic acid in patients undergoing chronic hemodialysis.
    Pönkä A; Kuhlbäck B
    Acta Med Scand; 1983; 213(4):305-7. PubMed ID: 6613689
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [L-ascorbic acid and its effect on oxalic acid excretion in the urine (author's transl)].
    Neshyba P; Louzenský G
    Cas Lek Cesk; 1981 Aug; 120(31-32):937-40. PubMed ID: 7261017
    [No Abstract]   [Full Text] [Related]  

  • 80. Safety of high-level vitamin C ingestion.
    Rivers JM
    Ann N Y Acad Sci; 1987; 498():445-54. PubMed ID: 3304071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.